UNCLASSIFIED THERAPEUTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
LANREOTIDE ACETATE: products 1 to 6 of 6.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Mytolac 120mg/Syr ER Pref Syr PkDIN 02555883 | General benefit | $1268.9722per source unit | Requirements & sourcesBuild cost plan |
| Mytolac 60mg/Syr ER Pref Syr PkDIN 02555867 | General benefit | $760.0056per source unit | Requirements & sourcesBuild cost plan |
| Mytolac 90mg/Syr ER Pref Syr PkDIN 02555875 | General benefit | $1013.7962per source unit | Requirements & sourcesBuild cost plan |
| Somatuline Autogel 120mg/Syr ER Pref Syr PkDIN 02283417 | General benefit | $1268.9722per source unit | Requirements & sourcesBuild cost plan |
| Somatuline Autogel 60mg/Syr ER Pref Syr PkDIN 02283395 | General benefit | $760.0056per source unit | Requirements & sourcesBuild cost plan |
| Somatuline Autogel 90mg/Syr ER Pref Syr PkDIN 02283409 | General benefit | $1013.7962per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
92:00 UNCLASSIFIED THERAPEUTIC AGENTS.
92:20 Biologic Response Modifiers.
92:36 Disease-Modifying Antirheumatic Agents.
92:44 Immunosuppressive Agents.
92:92 Other Miscellaneous Therapeutic Agents.